Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
McKinsey
Express Scripts
Johnson and Johnson
Baxter

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

FLUCYTOSINE - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Drug Prices for FLUCYTOSINE

See drug prices for FLUCYTOSINE

Recent Clinical Trials for FLUCYTOSINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 2/Phase 3
NRG OncologyPhase 2/Phase 3
University of Minnesota - Clinical and Translational Science InstitutePhase 1/Phase 2

See all FLUCYTOSINE clinical trials

Pharmacology for FLUCYTOSINE
Medical Subject Heading (MeSH) Categories for FLUCYTOSINE
Synonyms for FLUCYTOSINE
117969-88-7
130256-61-0
16469-EP2281563A1
16469-EP2316459A1
1LD
2-Hydroxy-4-amino-5-fluoro-pyrimidine
2-Hydroxy-4-amino-5-fluoropyrimidine
2-Pyrimidinol, 4-amino-5-fluoro- (9CI)
2(1H)-Pyrimidinone, 4-amino-5-fluoro-
2(1H)-Pyrimidinone, 4-amino-5-fluoro-)
2(1H)-Pyrimidinone, 6-amino-5-fluoro-
2022-85-7
22P857
4-Amino-1,2-dihydro-5-fluoro-2-oxopyrimidine
4-AMINO-2-HYDROXY-5-FLUOROPYRIMIDINE
4-Amino-5-fluoro-1H-pyrimidin-2-one
4-Amino-5-fluoro-2-hydroxypyrimidine
4-Amino-5-fluoro-2-hyroxypyrimidine
4-AMINO-5-FLUORO-2(1H)-PYRIMIDINE
4-Amino-5-fluoro-2(1H)-pyrimidinone
4-amino-5-fluoro-2(1H)-pyrimidinone; Flucytosine
4-amino-5-fluoro-pyrimidin-2-ol
4-amino-5-fluoropyrimidin-2-ol
4-Amino-5-fluoropyrimidin-2(1H)-one
5 Fluoro Cytosine
5-FC
5-Flucytosine
5-fluoro cytosine
5-fluoro-4-imino-1,3-dihydropyrimidin-2-one
5-Fluorocystosine
5-fluorocytocine
5-Fluorocytosin
5-Fluorocytosine
5-Fluorocytosine, 99+%
5-Fluorocytosine, Antibiotic for Culture Media Use Only
5-Fluorocytosine, nucleoside analog
5-Fluorocytosine, Vetec(TM) reagent grade, 99%
5-Flurocytosine
6-Amino-2-oxo-5-fluoropyrimidine
6-amino-5-fluoro-1,2-dihydropyrimidin-2-one
6-amino-5-fluoro-1H-pyrimidin-2-one
6-amino-5-fluoro-3-hydropyrimidin-2-one
6-amino-5-fluoropyrimidin-2(1H)-one
AB0005647
AB00444223-16
AB00513969
AB00513969_03
AB00513969_04
AB00513969-02
AB0071040
AB1000113
AC-11748
AC1L1FRT
AC1Q52OQ
ACMC-209zxs
AJ-24237
AK-33991
AKOS004912683
AKOS005063821
AKOS015896898
AKOS030241326
Alcobon
AM20090149
AMX10130
AN-9456
Ancobon
Ancobon (TN)
Ancotil
Ancotyl
ANW-50846
B-7734
BC203393
BCP02877
BCP0726000281
BCP9000692
BP-30254
BPBio1_000956
BR-33991
BRD-K82143716-001-15-7
BSPBio_000868
C4H4FN3O
CAS-2022-85-7
CCG-100837
CCG-213434
CF-075
CHEBI:5100
CHEMBL1463
CPD000059047
CS-1935
CTK7B7906
CTK7E0508
CTK8A0854
Cytosine, 5-fluoro-
Cytosine, 5-fluoro- (6CI,7CI,8CI)
D00323
D83282DT06
DB-005380
DB01099
DSSTox_CID_3059
DSSTox_GSID_23059
DSSTox_RID_76856
DTXSID3023059
EC 217-968-7
EINECS 217-968-7
F-3010
F0321
Flucitosina
Flucitosina [DCIT]
Flucystine
Flucytosin
flucytosina
Flucytosine (5-FC)
Flucytosine (Ancobon)
Flucytosine (JP17/USP/INN)
Flucytosine [USAN:INN:BAN:JAN]
Flucytosine [USAN:USP:INN:BAN:JAN]
Flucytosine [USAN)
Flucytosine 2.0 mg/ml in Methanol
Flucytosine for system suitability, European Pharmacopoeia (EP) Reference Standard
Flucytosine, 5-Fluorocytosine
Flucytosine, European Pharmacopoeia (EP) Reference Standard
Flucytosine, Pharmaceutical Secondary Standard; Certified Reference Material
Flucytosine, United States Pharmacopeia (USP) Reference Standard
Flucytosine,(S)
Flucytosine(Ancobon)
Flucytosine|||6-Amino-5-fluoropyrimidin-2(1H)-one
Flucytosinum
Flucytosinum [INN-Latin]
Flucytosone
Fluocytosine
Fluorcytosine
FT-0601273
GS-5578
HMS1570L10
HMS2051M04
HMS2093J05
HMS2097L10
HMS2233I14
HMS3373L05
HMS3393M04
HMS3655G17
HMS3714L10
HSDB 3082
HY-B0139
I07-0006
KB-189054
KS-00000A18
KS-1060
LS-59140
LS40595
MCULE-7094058995
MFCD00006035
MFCD00006035 (97+%)
MLS000069463
MLS000759519
MLS001076503
MLS001424013
MolPort-000-155-561
MolPort-001-774-493
MolPort-002-317-353
NC00087
NCGC00016599-01
NCGC00016599-02
NCGC00016599-04
NCGC00016599-05
NCI60_000093
NSC 103805
NSC-103805
NSC-759130
NSC103805
NSC759130
Opera_ID_178
Pharmakon1600-01505429
Prestwick0_000934
Prestwick1_000934
Prestwick2_000934
Prestwick3_000934
QCR-271
Ro 2-9915
Ro 29915 E/265601
Ro-29915
s1666
SAM001246753
SBB000061
SC-09037
SCHEMBL14696800
SCHEMBL24063
SMR000059047
SPBio_003037
SR-01000721885
SR-01000721885-5
ST028644
STK292386
SW197278-3
SY004438
TL8001667
Tox21_110515
Tox21_110515_1
UNII-D83282DT06
WLN: T6MVNJ DZ EF
XRECTZIEBJDKEO-UHFFFAOYSA-N
ZB015095
ZINC896546
ZLC0185
zlchem 343

US Patents and Regulatory Information for FLUCYTOSINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc FLUCYTOSINE flucytosine CAPSULE;ORAL 204652-001 Jul 7, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Novel Labs Inc FLUCYTOSINE flucytosine CAPSULE;ORAL 204652-002 Jul 7, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Sigmapharm Labs Llc FLUCYTOSINE flucytosine CAPSULE;ORAL 201566-002 Jun 28, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Sigmapharm Labs Llc FLUCYTOSINE flucytosine CAPSULE;ORAL 201566-001 Jun 28, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Recipharm FLUCYTOSINE flucytosine CAPSULE;ORAL 207536-001 Jun 18, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Recipharm FLUCYTOSINE flucytosine CAPSULE;ORAL 207536-002 Jun 18, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
AstraZeneca
McKinsey
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.